This is a clerical correction with no trading implications. Monitor the original PIPE offering's closing and any subsequent dilution impact.
Price Chart
Executive Summary
Atrium Therapeutics filed an 8-K/A to correct the share count disclosed in its October 8, 2026 original 8-K regarding a PIPE offering. The amendment revises the post-offering shares outstanding to 21,571,507 (including shares from make-whole equity awards tied to the Avidity spin-off), with no other changes. This is a purely administrative correction with no new material information.
Key Facts
- Amendment No. 1 to the October 8, 2026 8-K correcting the post-offering share count.
- PIPE offering of 5,170,384 common shares plus pre-funded warrants for up to 1,134,930 shares.
- Post-offering shares outstanding: 21,571,507, including shares from make-whole equity awards related to the Avidity spin-off.
- No other information was revised from the original filing.
Financial Impact
Correction of share count only; no new financial figures disclosed.
Risk Factors
- No new risks identified beyond those in the original PIPE offering.
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K/A Filing (Primary) | 0001193125-26-418417 |
| Document: 0001193125-26-418417-index-headers.html | 0001193125-26-418417 |
| Document: 0001193125-26-418417-index.html | 0001193125-26-418417 |
| Document: 0001193125-26-418417.txt | 0001193125-26-418417 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 27, 2026 today | 8-K | $8.20 | awaiting T+5 | — | $8.32 (+1.46%) |
Oct 20, 2026 7d ago | Press Release | $8.00 | awaiting T+5 | — | $8.32 (+4.00%) |
Oct 9, 2026 18d ago | 8-K/A | $8.40 $7.67 | ▼ −8.69% | ▼ −6.72% | $8.32 (−0.95%) |
Oct 8, 2026 19d ago | 8-K | $8.26 $7.82 | ▲ +5.33% | ▲ +5.05% | $8.32 (−0.73%) |
Sep 21, 2026 5w ago | Press Release | $9.22 $8.42 | ▼ −8.68% | ▼ −7.49% | $8.32 (−9.76%) |
Aug 20, 2026 9w ago | Press Release | $13.20 $13.64 | ▲ +3.33% | ▲ +2.86% | $8.32 (−36.97%) |
Aug 13, 2026 10w ago | 8-K | $12.84 $13.20 | ▲ +2.80% | ▲ +4.17% | $8.32 (−35.20%) |
Aug 13, 2026 10w ago | Press Release | $12.84 $13.20 | ▲ +2.80% | ▲ +4.17% | $8.32 (−35.20%) |
Jul 20, 2026 14w ago | Press Release | $12.29 $11.57 | ▼ −5.86% | ▼ −4.63% | $8.32 (−32.30%) |
Jul 14, 2026 15w ago | 8-K | $12.30 $12.17 | ▼ −1.06% | ▼ −0.08% | $8.32 (−32.36%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers